A novel method to identify and monitor endogenous tumor-reactive T cells by high expression of CD11a (LFA-1) and PD-1 (CD279) as immunologic readout for evaluating the efficacy of PD-1 blockade.
Haidong Dong
No relevant relationships to disclose
Svetomir Markovic
No relevant relationships to disclose
Christopher J Krco
No relevant relationships to disclose
Eugene D. Kwon
No relevant relationships to disclose